Abstract
Lung cancer is the leading cause of cancer deaths within the United States, yet prior studies have shown a lack of adherence to imaging and treatment guidelines in patients with lung cancer. This paper evaluates the use of FDG PET/CT imaging prior to subsequent radiation therapy in patients with non-small cell lung cancer, as recommended by National Comprehensive Cancer Network (NCCN) guidelines, and whether the use of this imaging modality impacts cancer-specific survival. Methods: This was a retrospective study of the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program Medicare linked data in patients with non-small cell lung cancer. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cancer-specific survival were estimated for patients diagnosed between 2006-2015 who underwent either FDG PET/CT or CT based imaging prior to subsequent radiation therapy. Results: Significant improvement in cancer-specific survival was found in patients who had FDG PET/CT imaging prior to subsequent radiation therapy, compared to those who underwent CT (HR, 1.43; 95% CI, 1.32-1.55, P <0.0001). While the NCCN recommends FDG PET/CT prior to subsequent radiation therapy, 43.6% of patients were imaged with CT alone. Conclusion: Many patients with non-small cell lung cancer are not being imaged according to national guidelines prior to subsequent radiation, which is associated with a lower cancer specific survival.
- Copyright © 2022 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user